Support Needs and Preferences of Family Caregivers of Lung Cancer Patients

Sponsor

Memorial Sloan Kettering Cancer Center (Other)

Overall Status

Completed

CT.gov ID

NCT00967083

Collaborator

Queens Cancer Center of Queens Hospital (Other), Michigan State University (Other), National Cancer Institute (NCI) (NIH), Indiana University (Other)

Enrollment

Locations

Duration (Months)

26.5

Patients Per Site

0.4

Patients Per Site Per Month

Study Details

Study Description

Brief Summary

This study is being done to learn what the needs are in relation to the family members. Some family members seek counseling; others do not. The institution wants to try to understand why and wants to see if they can improve our support services for family members.

Condition or Disease	Intervention/Treatment	Phase
Lung Cancer	Behavioral: Questionnaires/Interviews

Study Design

Study Type:

Observational

Actual Enrollment :

53 participants

Observational Model:

Cohort

Time Perspective:

Prospective

Official Title:

Support Needs and Preferences of Family Caregivers of Lung Cancer Patients

Study Start Date :

Aug 1, 2009

Actual Primary Completion Date :

Dec 1, 2014

Actual Study Completion Date :

Dec 1, 2014

Arms and Interventions

Arm	Intervention/Treatment
family caregivers of lung cancer patients In this 2-year pilot study, we plan to screen family caregivers of lung cancer patients within 4 to 6 weeks after the a new visit to the thoracic clinic. We will screen spouses, adult children, and other family members using the HAD-18 to determine their level of anxiety and depressive symptoms at enrollment.	Behavioral: Questionnaires/Interviews Baseline assessment of distressed caregivers within 4-6 weeks a new visit to the thoracic clinic. Three-month follow-up assessment of caregivers. Qualitative phone interviews with a subsample of 30 caregivers within 3 weeks of follow-up.

Arm

Intervention/Treatment

family caregivers of lung cancer patients

In this 2-year pilot study, we plan to screen family caregivers of lung cancer patients within 4 to 6 weeks after the a new visit to the thoracic clinic. We will screen spouses, adult children, and other family members using the HAD-18 to determine their level of anxiety and depressive symptoms at enrollment.

Behavioral: Questionnaires/Interviews

Baseline assessment of distressed caregivers within 4-6 weeks a new visit to the thoracic clinic. Three-month follow-up assessment of caregivers. Qualitative phone interviews with a subsample of 30 caregivers within 3 weeks of follow-up.

Outcome Measures

Primary Outcome Measures

Assess psychosocial info & practical needs of prim family caregivers of lung cancer pts.Mental health (anxiety & depression)& behavioral health needs(smoking cessation,alcohol abuse)will be assessed b/c these 2 types of needs are strongly correlate [13 to 16 weeks]

Secondary Outcome Measures

To assess psychosocial and practical barriers to psychosocial support service use among primary family caregivers of lung cancer patients [13 to 16 weeks]
To assess family caregivers' preferences (preferred topics, modality, provider, timing) regarding psychosocial support interventions. [13 to 16 weeks]
To gather descriptive information regarding participant flow for planning future intervention studies. [13 to 16 weeks]

Eligibility Criteria

Criteria

Ages Eligible for Study:

18 Years and Older

Sexes Eligible for Study:

All

Accepts Healthy Volunteers:

Yes

Inclusion Criteria:

Primary family caregiver identified by a patient who is approximately within 4 to 6 weeks of a new visit to a thoracic clinic and receiving cancer care at Memorial Sloan-Kettering Cancer Center or Queens Cancer Center
Caregiver is at least 18 years of age.
Caregiver has adequate English fluency for completion of data collection. The surveys were designed and validated in English and are not currently available in other languages. Translation of questionnaires into other languages would require reestablishing the reliability and validity of these measures. Therefore, participants must be able to communicate in English to complete the surveys.
Clinically meaningful distress defined as a score of 8 or greater on the Anxiety or Depression subscale of the HADS (see Bjelland et al., 2002; Zigmond & Snaith, 1983).

Exclusion Criteria:

Patients or caregivers exhibiting significant psychiatric or cognitive impairment (dementia/delirium, retardation, active psychosis) that in the judgment of the investigators would preclude providing informed consent and study participation
Patient has lung cancer recurrence
Currently participating in a psychosocial intervention trial